Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Rating of “Buy” from Brokerages
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating on the […]
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have earned an average recommendation of “Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating on the […]
